Combination of chemotherapy and photodynamic therapy using graphene oxide as drug delivery system

Journal of Photochemistry and Photobiology B: Biology

Volumn 135, Issue , 2014, Pages 7-16

  Zhou, Lin ^a,c   Wei, Shaohua ^a   Ge, Xuefeng ^a   Zhou, Jiahong ^a   Jiang, Huijun ^b   Li, Fuyou ^d   Shen, Jian ^a  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c JIANGSU UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

7 Ethyl 10 hydroxycamptothecin; Combination therapy; Graphene oxide; Hypocrellin A

Indexed keywords

FIRTECAN; GRAPHENE OXIDE; HYPOCRELLIN A; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG CARRIER; GRAPHITE; IRINOTECAN; OXIDE; PERYLENE; PHOTOSENSITIZING AGENT; QUINONE DERIVATIVE; SINGLET OXYGEN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOTHERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; CHEMISTRY; METABOLISM; PHOTOCHEMOTHERAPY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CAMPTOTHECIN; CELL LINE, TUMOR; DRUG CARRIERS; GRAPHITE; HUMANS; OXIDES; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; QUINONES; SINGLET OXYGEN;

EID: 84899880016     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2014.04.010     Document Type: Article

References (52)

1. Z. Liu, J.T. Robinson, X.M. Sun, and H.J. Dai PEGylated nanographene oxide for delivery of water-insoluble cancer drugs J. Am. Chem. Soc. 130 2008 10876 10877
2. S.J. He, B. Song, D. Li, C.F. Zhu, W.P. Qi, Y.Q. Wen, L.H. Wang, S.P. Song, H. P Fang, and C.H. Fan A graphene nanoprobe for rapid, sensitive, and multicolor fluorescent DNA analysis Adv. Funct. Mater. 20 2010 453 459
3. L.M. Zhang, J.G. Xia, Q.H. Zhao, L.W. Liu, and Z.J. Zhang Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs Small 6 2010 537 544
4. B.A. Chen, M. Liu, L.M. Zhang, J. Huang, J.L. Yao, and Z.J. Zhang Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector J. Mater. Chem. 21 2011 7736 7741
5. K. Yang, J.M. Wan, S.A. Zhang, Y.J. Zhang, S.T. Lee, and Z.A. Liu In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice ACS Nano 5 2011 516 522
6. Q. Zhang, W.W. Li, T. Kong, R.G. Su, N. Li, Q. Song, M.L. Tang, L.W. Liu, and G.S. Cheng Tailoring the interlayer interaction between doxorubicin-loaded graphene oxide nanosheets by controlling the drug content Carbon 51 2013 164 172
7. X.C. Qin, Z.Y. Guo, Z.M. Liu, W. Zhang, M.M. Wan, and B.W. Yang Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy J. Photochem. Photobiol. B 120 2013 156 162
8. K. Yang, J.M. Wan, S. Zhang, B. Tian, Y.J. Zhang, and Z. Liu The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power Biomaterials 33 2012 2206 2214
9. K. Yang, L.L. Hu, X.X. Ma, S.Q. Ye, L. Cheng, X.Z. Shi, C.H. Li, Y.G. Li, and L. Zhang Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles Adv. Mater. 24 2012 1868 1872
10. K. Yang, L.Z. Feng, X.Z. Shi, and Z. Liu Nano-graphene in biomedicine: theranostic applications Chem. Soc. Rev. 42 2013 530 547
11. X.Y. Yang, X.Y. Zhang, Z.F. Liu, Y.F. Ma, Y. Huang, and Y. Chen High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide J. Phys. Chem. C 112 2008 17554 17558
12. X.M. Sun, Z. Liu, K. Welsher, J.T. Robinson, A. Goodwin, S. Zaric, and H.J. Dai Nano-graphene oxide for cellular imaging and drug delivery Nano Res. 1 2008 203 212
13. L. Zhou, H.J. Jiang, S.H. Wei, X.F. Ge, J.H. Zhou, and J. Shen High-efficiency loading of hypocrellin B on graphene oxide for photodynamic therapy Carbon 50 2012 5594 5604
14. L. Zhou, W. Wang, J. Tang, J.H. Zhou, H.J. Jiang, and J. Shen Graphene oxide noncovalent photosensitizer and its anticancer activity in vitro Chem. Eur. J. 17 2011 12084 12091
15. R.Y. Zhang, M. Hummelgard, G. Lv, and H. Olin Real time monitoring of the drug release of rhodamine B on graphene oxide Carbon 49 2011 1126 1132
16. L.Y. Feng, L. Wu, and X.G. Qu New horizons for diagnostics and therapeutic applications of graphene and graphene oxide Adv. Mater. 25 2013 168 186
17. L.B. Josefsen, and R.W. Boyle Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics Theranostics 2 2012 916 966
18. S. Kim, T.Y. Ohulchanskyy, H.E. Pudavar, R.K. Pandey, and P.N. Prasad Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy J. Am. Chem. Soc. 129 2007 2669 2675 (Pubitemid 46364075)
19. 2 hybrid Carbon 50 2012 994 1004
20. H.R. Xiao, B.S. Zhu, D.L. Wang, Y. Pang, L. He, X.F. Ma, R.B. Wang, C.Y. Jin, Y. Chen, and X.Y. Zhu Photodynamic effects of chlorin e6 attached to single wall carbon nanotubes through noncovalent interactions Carbon 50 2012 1681 1689
21. S.B. Brown, E.A. Brown, and I. Walker The present and future role of photodynamic therapy in cancer treatment Lancet Oncol. 5 2004 497 508 (Pubitemid 39069400)
22. R. Qiao, Z.H. Zeng, S.Q. Xia, J.H. Zhou, Y.Y. Liu, J.R. Chen, X.S. Wang, and B.W. Zhang Using electrostatic interactions to increase the photodamaging ability of hypocrellin B: synthesis and study of 2-(dimethylamino)ethanethiol- modied HB New J. Chem. 31 2007 196 198 (Pubitemid 46227046)
23. H. Deng, X. Liu, J. Xie, R. Yin, N.Y. Huang, Y. Gu, and J.Q. Zhao Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity J. Med. Chem. 55 2012 1910 1919
24. J. Hongrapipat, P. Kopeckova, J. Liu, S. Prakongpan, and J. Kopecek Combination chemotherapy and photodynamic therapy with Fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells Mol. Pharm. 5 2008 696 709
25. A. Khdair, H. Handa, G.Z. Mao, and J. Panyam Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro Eur. J. Pharm. Biopharm. 71 2009 214 222
26. A. Khdair, D. Chen, Y. Patil, L.N. Ma, Q.P. Dou, M.P.V. Shekhar, and J. Panyam Nano particle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance J. Controlled Release 141 2010 137 144
27. C.L. Peng, P.S. Lai, F.H. Lin, S.Y.H. Wu, and M.J. Shieh Dual chemotherapy and photodynamic therapy in an HT-29 human colon cancer xenograft model using SN-38-loaded chlorin-core star block copolymer micelles Biomaterials 30 2009 3614 3625
28. N.Z. Zhang, Y. Zhu, W. Pan, W.Q. Ma, and A.L. Shao Photodynamic therapy combined with local chemotherapy for the treatment of advanced esophagocardiac carcinoma Photodiagn. Photodyn. 4 2007 60 64 (Pubitemid 46274567)
29. M.F. Zuluaga, and N. Lange Combination of photodynamic therapy with anti-cancer agents Curr. Med. Chem. 15 2008 1655 1673
30. C. Conte, F. Ungaro, G. Maglio, P. Tirino, G. Siracusano, M.T. Sciortino, N. Leone, G. Palma, A. Barbieri, C. Arra, A. Mazzaglia, and F. Quaglia Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer J. Controlled Release 167 2013 40 52
31. W. Miao, G. Shim, S. Lee, Y.S. Choe, and Y.K. Oh Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer Biomaterials 34 2013 3402 3410
32. H. Hwang, R. Biswas, P.S. Chung, and J.C. Ahn Modulation of EGFR and ROS induced cytochrome c release by combination of photodynamic therapy and carboplatin in human cultured head and neck cancer cells and tumor xenograft in nude mice J. Photochem. Photobiol. B 128 2013 70 77
33. G.S. Trindade, S.L.A. Farias, V.M. Rumjanek, and M.A.M. Capella Methylene blue reverts multidrug resistance: sensitivity of multidrug resistant cells to this dye and its photodynamic action Cancer Lett. 151 2000 161 167 (Pubitemid 30156790)
34. D.V. Ratnam, V. Bhardwaj, and M.N.V. Kumar Simultaneous analysis of ellagic acid and coenzyme Q(10) by derivative spectroscopy and HPLC Talanta 70 2006 387 391 (Pubitemid 44223637)
35. K. Baba, H.E. Pudavar, I. Roy, T.Y. Ohulchanskyy, Y.H. Chen, R.K. Pandey, and P.N. Prasad New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug Mol. Pharm. 4 2007 289 297 (Pubitemid 46640605)
36. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 5 2005 161 171 (Pubitemid 40314948)
37. Q.Y. Li, X.Q. Deng, Y.G. Zu, H.Y. Lv, L. Su, L.P. Yao, Y. Zhang, and L. Li Cytotoxicity and topo I targeting activity of substituted 10-nitrogenous heterocyclic aromatic group derivatives of SN-38 Eur. J. Med. Chem. 45 2010 3200 3206
38. T. Bansal, A. Awasthi, M. Jaggi, R.K. Khar, and S. Talegaonkar Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies Talanta 76 2008 1015 1021
39. S. Shukla, and S. Saxena Spectroscopic investigation of confinement effects on optical properties of graphene oxide Appl. Phys. Lett. 98 2011 73104
40. P. Huang, C. Xu, J. Lin, C. Wang, X.S. Wang, C.L. Zhang, X.J. Zhou, S.W. Guo, and D.X. Cui Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy Theranostics 1 2011 240 250
41. L. Zhou, J.H. Liu, J. Zhang, S.H. Wei, Y.Y. Feng, J.H. Zhou, B.Y. Yu, and J. Shen A new sol-gel silica nanovehicle preparation for photodynamic therapy in vitro Int. J. Pharm. 386 2010 131 137
42. I. Roy, T.Y. Ohulchanskyy, H.E. Pudavar, E.J. Bergey, A.R. Oseroff, J. Morgan, T.J. Dougherty, and P.N. Prasad Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy J. Am. Chem. Soc. 125 2003 7860 7865 (Pubitemid 36782161)
43. M. Horie, L.K. Komaba, H. Fukui, H. Kato, S. Endoh, A. Nakamura, A. Miyauchi, J. Maru, E. Miyako, K. Fujita, Y. Hagihara, Y. Yoshida, and H. Iwahashi Evaluation of the biological influence of a stable carbon nanohorn dispersion Carbon 54 2013 155 167
44. R. Penjweini, H.G. Loew, M. Eisenbauer, and K.W. Kratky Modifying excitation light dose of novel photosensitizer PVP-hypericin for photodynamic diagnosis and therapy J. Photochem. Photobiol. B 120 2013 120 129
45. K. Maduray, and B. Odhav The in vitro photodynamic effect of laser activated gallium, indium and iron phthalocyanine chlorides on human lung adenocarcinoma cells J. Photochem. Photobiol. B 128 2013 58 63
46. D. Depan, J. Shah, and R.D.K. Misra Controlled release of drug from folate-decorated and graphene mediated drug delivery system: synthesis, loading efficiency, and drug release response Mater. Sci. Eng. C - Bio. S 31 2011 1305 1312
47. A.M. Kaushal, A.K. Chakraborti, and A.K. Bansal FTIR studies on differential intermolecular association in crystalline and amorphous states of structurally related non-steroidal anti-inflammatory drugs Mol. Pharm. 5 2008 937 945
48. L. Zhou, S.H. Wei, X.F. Ge, J.H. Zhou, B.Y. Yu, and J. Shen External heavy-atomic construction of photosensitizer nanoparticles for enhanced in vitro photodynamic therapy of cancer J. Phys. Chem. B 116 2012 12744 12749
49. F. Yan, and R. Kopelman The embedding of meta-tetra(hydroxyphenyl)- chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties Photochem. Photobiol. 78 2003 587 591
50. L. Zhou, J.H. Zhou, C. Dong, F. Ma, S.H. Wei, and J. Shen Water-soluble hypocrellin A nanoparticles as a photodynamic therapy delivery system Dyes Pigm. 82 2009 90 94
51. W. Tang, H. Xu, R. Kopelman, and M.A. Philbert Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms Photochem. Photobiol. 81 2005 242 249 (Pubitemid 40551499)
52. D.H. Shin, H.Y. Min, A.K. El-Naggar, S.M. Lippman, B. Glisson, and H.Y. Lee Akt/mammalian target of rapamycin counteract the antitumor activities of cixutumumab an anti-insulin-like growth factor I receptor monoclonal antibody Mol. Cancer Ther. 10 2011 2437 2448